According to two large-scale clinical researches based on Chinese breast cancer patients published in 2017, the authors reported negative results because BRCA1 mutation was not significantly correlated with poor prognosis in multivariate analysis [4, 5]. The gene discussed is BRCA1; the disease is breast carcinoma.